Featured News
Dr. Adam Friedman, professor and Chair of dermatology at the George Washington University School of Medicine and Health Sciences joined WTOP to debunk some of these myths and tell us what we can all do to try and prevent skin cancer.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision making is, why it is important in dermatology, as well as common challenging scenarios where shared decision making is particularly important to consider in the older…
Dr. Friedman spoke in this interview segment on improvements that have been made and improvements that he believes are needed to affect change regarding atopic dermatitis treatment disparities.
In this episode of The ElderDerm Podcast, co-hosts Dr. Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup, a new task force that is part of the International Dermatology Outcome Measures (IDEOM) organization. Get excited to hear about what is…
Vishal Patel, MD, FAAD, FACMS, discusses the evolving use of neoadjuvant and adjuvant PD-1 inhibition in cutaneous squamous cell carcinoma
George Washington University Dr. Adam Friedman joined FOX 5's Live Zone to talk more about the dangers of counterfeit Botox.
Dr. Vishal Patel, MD, Director of Cutaneous Oncology and Dermatologic Surgery is featured with WCTV in the discussion of Merkel Cell Carcinoma detailing the risks and the importance of skin cancer checks.
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, why there is a need for this area in training and announce the inaugural ElderDerm Conference, to be hosted at George Washington University in DC on June 6th, 2024.
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article for hyperhidrosis and the treatment options that varies based on the affected body areas.
Jonathan Silverberg, MD, PhD, MPH, of George Washington University School of Medicine and Health Sciences, explains the benefits of using Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD)